Amgen offers to acquire Nuevolution for $167 million

You are here: Home > Biotech > Current Article

Amgen offers to acquire Nuevolution for $167 million

By Staff Report / Wednesday, May 22nd, 2019 / Comments Off on Amgen offers to acquire Nuevolution for $167 million

Amgen, the $100 billion biotech giant based in Thousand Oaks, announced an all-cash offer May 22 to acquire Copenhagen-based research institute Nuevolution for $167 million. At $3.37 per share, the offer nearly triples the value of the stock, which closed May 21 at 12.1 Swedish krona, or $1.26 per share, on the Nasdaq Stockholm exchange.…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.